Veradigm Inc. has filed an 8-K with the Securities and Exchange Commission to disclose preliminary unaudited financial estimates for 2025 and provide an update on its strategic roadmap. The company reported an expected revenue range of $584 million to $589 million for the full year 2025.
In addition to revenue figures, the filing details the company's current financial position. As of the end of 2025, Veradigm expects to hold $120 million in cash and cash equivalents. The company also reported a debt balance of $75 million.
The filing outlines a strategic framework titled "Reset, Recover, Reignite." Management stated that revenue growth is expected to accelerate beginning in 2026. The company plans to achieve this growth by leveraging its Health Network Architecture, which connects providers, payers, and life sciences companies. This architecture is intended to provide independent physician practices with a real-time view of their clinical, financial, and operational performance.
Veradigm also detailed its product portfolio optimization strategy. The company intends to invest in and scale higher-growth solutions while rationalizing its product and solution portfolio. This includes rethinking product partnerships and maintaining a strong balance sheet to support growth initiatives.
Regarding regulatory compliance, the company noted that it has recently filed its 2023 and 2024 Form 10-Ks. An audit for 2025 is currently underway, with an expected filing in the later part of 2026. The company stated its intention to relist its shares on a national securities exchange once it is current with its SEC reporting obligations.
